ORY
Oryzon Genomics SA
European company
Healthcare
Biotechnology
/
NAV Price
-
Last Traded
-
Chg
-
-
XMAD
-
Updated: -
Times are shown in GMT+1, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
This stock can be held in:
/
Company Profile
Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics. It is engaged in the field of epigenetic medicine and in the development of therapeutic, biological solutions for cancer and neurodegenerative diseases.Oryzon Genomics SA is a clinical stage biopharmaceutical company and engaged in the development of epigenetics-based therapeutics.
XMAD:ORY
ES0167733015
EUR
Loading Comparison
Latest ORY News
Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News